SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-23-018721
Filing Date
2023-05-23
Accepted
2023-05-23 16:05:18
Documents
13
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 20518
2 ex99-1.htm EX-99.1 817990
3 ex99-2.htm EX-99.2 1872
4 ex99-3.htm EX-99.3 1728
5 ex99-1_001.jpg GRAPHIC 15585
6 ex99-1_002.jpg GRAPHIC 4713
7 ex99-1_003.jpg GRAPHIC 53109
8 ex99-2_001.jpg GRAPHIC 462336
9 ex99-2_002.jpg GRAPHIC 268660
10 ex99-3_001.jpg GRAPHIC 493999
11 ex99-3_002.jpg GRAPHIC 297085
12 form6-k_001.jpg GRAPHIC 8671
13 form6-k_002.jpg GRAPHIC 8671
  Complete submission text file 0001493152-23-018721.txt   3065764
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 23948942
SIC: 2834 Pharmaceutical Preparations